| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $0 ) |
| | 2026 | 2023 | MABSWITCH INC | 14693 1/2 SHERMAN WAY | VAN NUYS | CA | 91405-2213 | LOS ANGELES | USA | R43CA281387 | SaefCAR: Regulatable CAR-T cells for safe and effective immunotherapy | 000 | 1 | NIH | 1/20/2026 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $338,997 ) |
| | 2024 | 2024 | MABSWITCH INC | 15701 SHERMAN WAY | VAN NUYS | CA | 91409-8601 | LOS ANGELES | USA | R43TR004551 | LentiSAFE Ligands: Mild-Elution Immunoaffinity Ligands for Enrichment and Purification of Lentiviral Vectors | 000 | 1 | NIH | 12/28/2023 | $338,997 |
|
| Issue Date FY: 2023 ( Subtotal = $399,958 ) |
| | 2023 | 2023 | MABSWITCH INC | 15701 SHERMAN WAY | VAN NUYS | CA | 91409-8601 | LOS ANGELES | USA | R43CA281387 | SaefCAR: Regulatable CAR-T cells for safe and effective immunotherapy | 000 | 1 | NIH | 9/19/2023 | $399,958 |
|
|
